한글목차

세계 눈물샘용 기기 시장의 미래는 병원, 진단센터, 외래 치료 센터 시장에서의 기회로 인해 유망합니다. 세계 눈물샘용 기기 시장은 2025-2031년 연평균 복합 성장률(CAGR) 3.6%를 보일 것으로 예측됩니다. 이 시장의 주요 촉진요인은 고령화 인구의 급증, 안질환의 유병률 증가, 눈물샘용 기기의 지속적인 발전입니다.

• Lucintel의 예측에 따르면, 제품별로는 안질환의 유병률 증가로 인해 스텐트 튜브가 예측 기간 동안 가장 큰 부문을 차지할 것으로 예상했습니다.
• 최종 용도별로는 외과 수술을 받는 환자 수가 증가함에 따라 병원이 가장 큰 부문이 될 것으로 보입니다.
• 지역별로는 북미가 아이케어에 대한 소비자의 인식이 높아지고 정부 차원의 노력으로 인해 예측 기간 동안 가장 규모가 큰 지역으로 남을 것으로 보입니다.

눈물샘용 기기 시장의 전략적 성장 기회

눈물샘용 기기 시장은 주요 응용 분야에서 몇 가지 전략적 성장 기회를 제공합니다. 기업은 수요가 많고 미충족 수요가 있는 분야에 집중함으로써 이러한 기회를 활용하여 시장 입지를 확대하고 혁신을 추진할 수 있습니다. 이러한 성장 기회를 이해하면 이해관계자들이 새로운 트렌드를 활용하고 경쟁력을 강화하기 위해 전략을 조정하는 데 도움이 될 것입니다.

• 원격 의료 서비스 확대: 원격 의료의 성장은 눈물샘용 기기 시장에 큰 기회를 제공합니다. 원격 진료 및 진단을 통해 특히 의료 혜택이 부족한 지역에서 눈물샘 치료에 대한 접근성을 향상시킬 수 있습니다.
• 맞춤형 기기 개발: 기업은 원격 의료 플랫폼과 호환되는 기기를 개발함으로써 환자의 모니터링과 치료 순응도를 향상시킬 수 있습니다. 이러한 추세는 전문 의료 서비스에 대한 접근성이 제한적인 원격지나 지방의 환자들에게 특히 유용합니다.
• 개인맞춤형 의료에 대한 관심: 개인맞춤형 의료 트렌드는 3D 프린터와 이미징 기술의 발전으로 환자 개개인의 필요에 따라 맞춤형 눈물샘용 기기를 개발할 수 있는 기회를 열어주며, 편안함과 효과를 향상시킬 수 있습니다. 맞춤형 장치는 특정 해부학적 변화에 대응하고 치료 결과를 향상시킬 수 있습니다.
• 안구건조증 관리에 집중: 안구건조증 유병률이 증가함에 따라 안구건조증을 효과적으로 관리할 수 있도록 고안된 첨단 눈물샘용 기기에 대한 수요가 증가하고 있습니다. 안구건조증을 지속적으로 완화하고 환자의 삶의 질을 향상시킬 수 있는 기기 개발 및 시장 개척의 기회가 존재합니다. 눈물길 플러그와 스텐트의 기술 혁신은 특히 이러한 상황과 관련이 있습니다.
• 신흥 시장 투자: 신흥 시장, 특히 아시아와 아프리카의 신흥 시장은 의료 접근성과 인식이 높아짐에 따라 큰 성장 기회를 제공합니다. 기업들은 이러한 확대되는 시장에 대응하기 위해 현지 제조 파트너십과 유통 네트워크를 모색할 수 있습니다. 현지의 니즈와 경제성에 맞게 제품을 조정하는 것이 시장 점유율을 확보하는 열쇠가 될 수 있습니다.
• 웨어러블 기술과의 통합: 눈물샘용 기기와 웨어러블 기술의 통합은 새로운 기회입니다. 안구 건강 상태를 모니터링하고 치료 과정을 추적하는 웨어러블 기기는 의료진에게 귀중한 데이터를 제공할 수 있습니다. 이러한 통합은 사전 예방적 관리와 개인화된 치료 계획을 지원하고, 환자 참여와 치료를 강화할 수 있습니다.

이러한 전략적 성장 기회는 기술 혁신을 촉진하고, 접근성을 확대하며, 환자의 다양한 요구를 충족시킴으로써 눈물샘용 기기 시장을 재편하고 있습니다. 원격 의료, 맞춤형 기기, 안구건조증 관리, 신흥 시장 및 웨어러블 기술에 대한 투자는 시장에서의 입지를 강화하고 환자 결과를 개선하고자 하는 기업들에게 로드맵을 제공할 것입니다.

눈물샘용 기기 시장 성장 촉진요인 및 과제

눈물샘용 기기 시장은 성장과 개척을 형성하는 다양한 촉진요인 및 과제에 의해 영향을 받습니다. 이러한 요인에는 기술 발전, 경제 상황, 규제 변화 등이 포함됩니다. 이해관계자들이 시장을 효과적으로 탐색하고 정보에 입각한 전략적 의사결정을 내리기 위해서는 이러한 촉진요인과 과제를 이해하는 것이 매우 중요합니다.

눈물샘용 기기 시장을 이끄는 요인은 다음과 같습니다.

• 기술 발전: 스마트 눈물샘용 기기 및 최소침습적 기술 등 지속적인 기술 혁신이 시장 성장을 가속하고 있습니다. 재료 및 제조 공정의 발전은 장치의 성능과 환자의 편안함을 향상시킵니다. 이러한 기술들은 치료 결과의 향상과 눈물길 장치의 채택 확대에 기여하고 있습니다.
• 안질환 유병률 증가: 안질환, 특히 안구건조증과 눈물샘 질환의 유병률 증가는 눈물샘용 기기 시장의 중요한 촉진요인입니다. 전 세계 인구의 고령화와 생활습관이 눈 건강 문제의 원인이 되고 있어 효과적인 치료 솔루션에 대한 수요가 증가하고 있습니다.
• 환자 인식 증가: 눈 건강과 치료법에 대한 인식이 높아지면서 시장 성장의 원동력이 되고 있습니다. 환자들은 눈물샘 질환에 대한 지식이 높아지면서 적극적으로 해결책을 찾고 있습니다. 이러한 인식 증가는 눈물샘용 기기에 대한 수요 증가와 안과 의료 서비스 접근성 향상으로 이어질 것입니다.
• 혁신에 대한 규제 지원: 신속한 승인 절차, 간소화된 규제 등 주요 시장의 지원적인 규제 환경은 기술 혁신을 촉진하고 새로운 기기 시장 진입을 용이하게 합니다. 이러한 규제적 지원은 첨단 눈물샘용 기기의 개발과 보급을 가속화하는 데 도움이 됩니다.
• 의료 인프라에 대한 투자: 특히 신흥 시장의 의료 인프라에 대한 투자는 안과 의료 서비스에 대한 접근성을 확대하고 있습니다. 의료 시설의 개선과 안과 치료에 대한 보조금 증가는 눈물샘용 기기 수요를 촉진하고 시장 성장에 기여하고 있습니다.

눈물샘용 기기 시장의 과제는 다음과 같습니다.

• 첨단 장치의 높은 비용: 첨단 눈물샘용 기기의 높은 비용은 특히 개발도상국에서 보급의 장벽이 될 수 있습니다. 첨단 기술과 관련된 비용은 접근성 및 구매 가능한 가격을 제한하여 시장 성장과 환자 접근에 영향을 미칠 수 있습니다.
• 규제적 장애물: 지역마다 다른 복잡한 규제 요건을 극복하는 것은 제조업체에게 큰 도전이 될 수 있습니다. 긴 승인 과정과 다양한 표준을 준수해야 하는 등 규제 장벽은 제품 출시를 지연시키고 비용을 증가시킬 수 있습니다.
• 신흥 지역 시장 침투 지연: 성장 기회는 있지만, 의료 인프라 미비, 낮은 인지도 등의 요인으로 인해 신흥 지역에서 시장 침투는 여전히 제한적입니다. 이러한 장벽을 극복하기 위해서는 접근성과 인지도를 높이기 위한 타겟팅된 전략이 필요합니다.

눈물샘용 기기 시장은 기술 발전, 안질환 유병률 증가, 환자 인식 개선, 규제 지원, 의료 인프라에 대한 투자에 힘입어 성장하고 있습니다. 그러나 높은 기기 비용, 규제 장애물, 신흥 지역에서 시장 침투 한계 등의 문제도 해결해야 할 과제입니다. 이러한 시장 성장 촉진요인과 과제를 이해하는 것은 이해관계자들이 기회를 포착하고 복잡한 시장을 헤쳐나가기 위해 필수적입니다.

목차

제1장 주요 요약

제2장 세계의 눈물샘용 기기 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계 촉진요인과 과제

제3장 시장 동향과 예측 분석(2019년-2031년)

• 거시경제 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 눈물샘용 기기 시장 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 눈물샘용 기기 시장 : 제품별
  • 삽관 세트
  • 스텐트 및 튜브
  • 캐뉼라 및 스파츌라(Spatula)
  • 확장기
• 세계의 눈물샘용 기기 시장 : 용도별
  • 녹내장
  • 안구건조증
  • 눈물샘 염증
  • 에피포라
  • 기타
• 세계의 눈물샘용 기기 시장 : 최종 용도별
  • 병원
  • 진단센터
  • 외래 치료 센터(ACC)

제4장 지역별 시장 동향과 예측 분석(2019년-2031년)

• 세계의 눈물샘용 기기 시장 : 지역별
• 북미의 눈물샘용 기기 시장
• 유럽의 눈물샘용 기기 시장
• 아시아태평양의 눈물샘용 기기 시장
• 기타 지역의 눈물샘용 기기 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter의 Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 세계의 눈물샘용 기기 시장 성장 기회 : 유형별
  • 세계의 눈물샘용 기기 시장 성장 기회 : 용도별
  • 세계의 눈물샘용 기기 시장 성장 기회 : 최종 용도별
  • 세계의 눈물샘용 기기 시장 성장 기회 : 지역별
• 세계 눈물샘용 기기 시장의 새로운 동향
• 전략적 분석
  • 신제품 개발
  • 세계의 눈물샘용 기기 시장 생산능력 확대
  • 세계 눈물샘용 기기 시장의 인수합병(M&A) 및 합작투자(JV)
  • 인증 및 라이선싱

제7장 주요 기업 개요

• FCI Ophthalmic
• Kaneka
• Lacrimedics
• Cook
• BVI
• Rumex International
• Bess Medical Technology

영문목차

The future of the global lacrimal device market looks promising with opportunities in the hospital, diagnostic center, and ambulatory care center markets. The global lacrimal device market is expected to grow with a CAGR of 3.6% from 2025 to 2031. The major drivers for this market are a surge in the aging population, increasing prevalence of eye disease, and ongoing advancement in lacrimal devices.

• Lucintel forecasts that, within the product category, stent and tube will remain the largest segment over the forecast period due to the increasing prevalence of eye diseases.
• Within the end-use category, hospitals will remain the largest segment due to the rising number of patients undergoing surgical procedures.
• In terms of region, North America will remain the largest region over the forecast period due to rising consumer awareness about eye care and government initiatives.

Gain valuable insight for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Lacrimal Device Market

The lacrimal device market is undergoing transformative changes driven by technological advancements, evolving patient needs, and an increased focus on personalized medicine. These emerging trends are shaping market dynamics, influencing product development, and altering competitive landscapes. Understanding these trends provides valuable insights into the future direction of the industry and highlights opportunities for innovation and growth.

• Integration of Digital Technologies: Digital technologies, including AI and machine learning, are increasingly being integrated into lacrimal devices. These advancements improve diagnostic accuracy and enable real-time monitoring of device performance. AI algorithms can analyze patient data to personalize treatment plans, enhancing overall efficacy and patient outcomes.
• Minimally Invasive Procedures: There is a growing trend toward minimally invasive lacrimal procedures. Devices that require smaller incisions or non-surgical methods are becoming more popular due to reduced recovery times and a lower risk of complications. This trend is driven by patient preference for less invasive treatments and advancements in device technology.
• Personalized Medicine: Personalized medicine is gaining traction in the lacrimal device market. Customizable devices tailored to individual patient anatomy and needs are becoming more common. This trend is supported by advancements in 3D printing and imaging technologies, which allow for more precise and effective treatments.
• Smart Devices and Connectivity: The development of smart lacrimal devices with embedded sensors and connectivity features is on the rise. These devices can transmit data to healthcare providers, facilitating remote monitoring and management. Connectivity enhances patient engagement and allows for timely interventions based on real-time data.
• Expansion in Emerging Markets: Emerging markets, particularly in Asia and Africa, are experiencing significant growth in the lacrimal device sector. Increased healthcare access, rising awareness, and local manufacturing are contributing to this expansion. Companies are focusing on developing affordable and accessible solutions to meet the needs of these growing markets.

These trends are reshaping the lacrimal device market by driving innovation, enhancing patient care, and expanding market reach. The integration of digital technologies, minimally invasive procedures, and personalized medicine is improving treatment outcomes, while smart devices and connectivity offer new possibilities for remote management. The growth in emerging markets further highlights the global expansion of the industry and the need for adaptable, cost-effective solutions.

Recent Developments in the Lacrimal Device Market

Recent key developments in the lacrimal device market reflect a combination of technological advancements, regulatory changes, and evolving patient needs. These developments enhance the efficacy, safety, and accessibility of lacrimal devices, influencing market dynamics across various regions. Understanding these developments provides insight into how the market is progressing and what to expect shortly.

• Introduction of Smart Lacrimal Devices: The development of smart lacrimal devices equipped with sensors and connectivity features is a significant advancement. These devices enable real-time monitoring and data collection, which can be used to optimize treatment plans and improve patient outcomes. The integration of IoT technology allows for remote monitoring and better management of lacrimal conditions.
• Advancements in Minimally Invasive Techniques: Recent advancements in minimally invasive techniques have led to the creation of new lacrimal devices that offer reduced procedural invasiveness. These innovations include smaller, more flexible stents and plugs that minimize discomfort and recovery time. Such advancements are driven by the increasing demand for patient-friendly treatment options.
• Regulatory Approvals for New Technologies: The regulatory landscape has evolved to accommodate new lacrimal device technologies. Recent approvals by regulatory bodies, such as the FDA and CE, for advanced lacrimal devices have facilitated market entry and increased competition. These approvals are crucial for ensuring that new technologies meet safety and efficacy standards.
• Growth in Local Manufacturing Capabilities: There has been a noticeable increase in local manufacturing capabilities, especially in emerging markets. This development is driven by the need to reduce costs and improve accessibility. Local manufacturing also supports faster product availability and customization based on regional needs.
• Increased Investment in Research and Development: Investment in research and development (R&D) has surged, leading to innovative lacrimal device solutions. Companies are focusing on developing new materials, improving device functionality, and exploring novel treatment approaches. This emphasis on R&D is critical for advancing technology and addressing unmet clinical needs.

These key developments significantly impact the lacrimal device market by enhancing technology, improving patient care, and expanding market opportunities. The introduction of smart devices, advancements in minimally invasive techniques, and regulatory approvals drive growth, while increased local manufacturing and investment in R&D foster innovation and accessibility.

Strategic Growth Opportunities for Lacrimal Device Market

The lacrimal device market presents several strategic growth opportunities across key applications. By focusing on areas with high demand and unmet needs, companies can leverage these opportunities to expand their market presence and drive innovation. Understanding these growth opportunities helps stakeholders align their strategies to capitalize on emerging trends and enhance their competitive edge.

• Expansion of Telemedicine Services: The growth of telemedicine offers significant opportunities for the lacrimal device market. Remote consultations and diagnostics can enhance the accessibility of lacrimal care, especially in underserved areas.
• Development of Customizable Devices: Companies can develop devices compatible with telehealth platforms to improve patient monitoring and treatment adherence. This trend is particularly beneficial for patients in remote or rural locations who have limited access to specialized care.
• Focus on Personalized Medicine: The trend toward personalized medicine opens up opportunities for developing customizable lacrimal devices. Advances in 3D printing and imaging technologies allow for the creation of devices tailored to individual patient needs, improving comfort and efficacy. Customizable devices can address specific anatomical variations and enhance treatment outcomes.
• Focus on Dry Eye Disease Management: With the increasing prevalence of dry eye disease, there is a growing demand for advanced lacrimal devices designed to manage this condition effectively. Opportunities exist to develop and market devices that provide sustained relief and improve patient quality of life. Innovations in tear duct plugs and stents are particularly relevant in this context.
• Investment in Emerging Markets: Emerging markets, particularly in Asia and Africa, present significant growth opportunities due to rising healthcare access and awareness. Companies can explore local manufacturing partnerships and distribution networks to cater to these expanding markets. Tailoring products to meet regional needs and affordability will be key to capturing market share.
• Integration with Wearable Technology: The integration of lacrimal devices with wearable technology is an emerging opportunity. Wearable devices that monitor ocular health and track treatment progress can provide valuable data for healthcare providers. This integration supports proactive management and personalized treatment plans, enhancing patient engagement and care.

These strategic growth opportunities are reshaping the lacrimal device market by driving innovation, expanding access, and addressing diverse patient needs. The focus on telemedicine, customizable devices, and dry eye management, along with investment in emerging markets and wearable technology, provides a roadmap for companies seeking to enhance their market presence and improve patient outcomes.

Lacrimal Device Market Driver and Challenges

The lacrimal device market is influenced by a range of drivers and challenges that shape its growth and development. These factors include technological advancements, economic conditions, and regulatory changes. Understanding these drivers and challenges is crucial for stakeholders to navigate the market effectively and make informed strategic decisions.

The factors responsible for driving the lacrimal device market include:

• Technological Advancements: Ongoing technological innovations, such as smart lacrimal devices and minimally invasive techniques, are driving market growth. Advancements in materials and manufacturing processes enhance device performance and patient comfort. These technologies contribute to improved treatment outcomes and increased adoption of lacrimal devices.
• Rising Prevalence of Eye Disorders: The increasing prevalence of eye disorders, particularly dry eye disease and lacrimal system disorders, is a significant driver for the lacrimal device market. As the global population ages and lifestyle factors contribute to eye health issues, there is a growing demand for effective treatment solutions.
• Growing Patient Awareness: Increased awareness about eye health and available treatments is driving market growth. Patients are more informed about lacrimal system disorders and are actively seeking solutions. This heightened awareness leads to increased demand for lacrimal devices and improved access to ophthalmic care.
• Regulatory Support for Innovation: Supportive regulatory environments in key markets, such as expedited approval processes and streamlined regulations, encourage innovation and facilitate market entry for new devices. This regulatory support helps accelerate the development and adoption of advanced lacrimal devices.
• Investment in Healthcare Infrastructure: Investments in healthcare infrastructure, particularly in emerging markets, are expanding access to eye care services. Improved healthcare facilities and increased funding for ophthalmic treatments drive demand for lacrimal devices and contribute to market growth.

Challenges in the lacrimal device market include:

• High Cost of Advanced Devices: The high cost of advanced lacrimal devices can be a barrier to widespread adoption, particularly in developing regions. The expense associated with cutting-edge technologies may limit access and affordability, impacting market growth and patient access.
• Regulatory Hurdles: Navigating complex and varying regulatory requirements across different regions can pose challenges for manufacturers. Regulatory hurdles, including lengthy approval processes and compliance with diverse standards, can delay product launches and increase costs.
• Limited Market Penetration in Emerging Regions: Despite growth opportunities, market penetration in emerging regions remains limited due to factors such as inadequate healthcare infrastructure and low awareness. Addressing these barriers requires targeted strategies to improve access and awareness.

The lacrimal device market is driven by technological advancements, rising eye disorder prevalence, growing patient awareness, regulatory support, and investments in healthcare infrastructure. However, challenges such as high device costs, regulatory hurdles, and limited market penetration in emerging regions must be addressed. Understanding these drivers and challenges is essential for stakeholders to capitalize on opportunities and navigate the complexities of the market.

List of Lacrimal Device Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies lacrimal device companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the lacrimal device companies profiled in this report include-

• FCI Ophthalmic
• Kaneka
• Lacrimedics
• Cook
• BVI
• Rumex International
• Bess Medical Technology

Lacrimal Device by Segment

The study includes a forecast for the global lacrimal device market by product, application, end use, and region.

Lacrimal Device Market by Product [Analysis by Value from 2019 to 2031]:

• Intubation Sets
• Stents and Tubes
• Cannula and Spatula
• Dilators

Lacrimal Device Market by Application [Analysis by Value from 2019 to 2031]:

• Glaucoma
• Dry Eye
• Lacrimal Gland Inflammation
• Epiphora
• Others

Lacrimal Device Market by End Use [Analysis by Value from 2019 to 2031]:

• Hospital
• Diagnostic Center
• Ambulatory Care Center (ACC)

Lacrimal Device Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Lacrimal Device Market

The lacrimal device market has been evolving rapidly due to advancements in technology, increasing patient awareness, and varying regional needs. Key markets such as the United States, China, Germany, India, and Japan have shown diverse trends influenced by local healthcare policies, economic conditions, and technological innovations. This growth reflects a broader global trend toward improving ophthalmic care and addressing lacrimal system disorders. Each region is experiencing unique developments that are shaping the future of this specialized medical sector.

• United States: The U.S. lacrimal device market has seen significant advancements with the introduction of new, minimally invasive technologies. Innovations such as smart lacrimal stents and improved tear duct plugs have gained traction, driven by increasing demand for effective dry eye treatments. The regulatory environment in the U.S. has supported these advancements through expedited approval processes for novel devices. Additionally, there has been a rise in partnerships between technology companies and healthcare providers to enhance patient outcomes and device functionality.
• China: In China, the lacrimal device market is growing rapidly due to increasing healthcare investments and rising awareness about eye health. The country has seen a surge in domestic manufacturing of lacrimal devices aimed at reducing dependency on imports and catering to local needs. Additionally, there has been a push toward integrating digital technologies and AI in diagnostics and treatment, which is expected to improve the accuracy and efficiency of lacrimal device usage.
• Germany: Germany remains a leader in lacrimal device technology in Europe, with a strong focus on research and development. Recent developments include the introduction of advanced materials for lacrimal stents that enhance patient comfort and device longevity. The German market benefits from a well-established healthcare infrastructure and stringent regulatory standards that ensure high-quality devices. Collaboration between academic institutions and industry players has fostered innovation and kept Germany at the forefront of lacrimal device advancements.
• India: In India, the lacrimal device market is expanding due to the increasing prevalence of lacrimal system disorders and growing access to healthcare. Recent developments include cost-effective, locally manufactured devices designed to meet the needs of a diverse patient population. The rise of telemedicine and remote diagnostics in India is also influencing the market, providing new avenues for early detection and management of lacrimal issues. Moreover, government initiatives aimed at improving eye care infrastructure are contributing to market growth.
• Japan: Japan's lacrimal device market is characterized by high technological integration and patient-centric innovations. Recent developments include the adoption of advanced robotics and automation in lacrimal system procedures. Japan's strong focus on precision medicine and personalized treatment has led to the development of customized lacrimal devices that cater to individual patient needs. The country's stringent regulatory environment ensures that new technologies meet high standards of safety and efficacy.

Features of the Global Lacrimal Device Market

Market Size Estimates: Lacrimal device market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Lacrimal device market size by product, application, end use, and region in terms of value ($B).

Regional Analysis: Lacrimal device market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, applications, end uses, and regions for the lacrimal device market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the lacrimal device market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the lacrimal device market by product (intubation sets, stents and tubes, cannula and spatula, and dilators), application (glaucoma, dry eye, lacrimal gland inflammation, epiphora, and others), end use (hospital, diagnostic center, and ambulatory care center (ACC)), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Lacrimal Device Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Lacrimal Device Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Lacrimal Device Market by Product
  • 3.3.1: Intubation Sets
  • 3.3.2: Stents and Tubes
  • 3.3.3: Cannula and Spatula
  • 3.3.4: Dilators
• 3.4: Global Lacrimal Device Market by Application
  • 3.4.1: Glaucoma
  • 3.4.2: Dry Eye
  • 3.4.3: Lacrimal Gland Inflammation
  • 3.4.4: Epiphora
  • 3.4.5: Others
• 3.5: Global Lacrimal Device Market by End Use
  • 3.5.1: Hospital
  • 3.5.2: Diagnostic Center
  • 3.5.3: Ambulatory Care Center (ACC)

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Lacrimal Device Market by Region
• 4.2: North American Lacrimal Device Market
  • 4.2.1: North American Market by Product: Intubation Sets, Stents and Tubes, Cannula and Spatula, and Dilators
  • 4.2.2: North American Market by End Use: Hospital, Diagnostic Center, and Ambulatory Care Center (ACC)
• 4.3: European Lacrimal Device Market
  • 4.3.1: European Market by Product: Intubation Sets, Stents and Tubes, Cannula and Spatula, and Dilators
  • 4.3.2: European Market by End Use: Hospital, Diagnostic Center, and Ambulatory Care Center (ACC)
• 4.4: APAC Lacrimal Device Market
  • 4.4.1: APAC Market by Product: Intubation Sets, Stents and Tubes, Cannula and Spatula, and Dilators
  • 4.4.2: APAC Market by End Use: Hospital, Diagnostic Center, and Ambulatory Care Center (ACC)
• 4.5: ROW Lacrimal Device Market
  • 4.5.1: ROW Market by Product: Intubation Sets, Stents and Tubes, Cannula and Spatula, and Dilators
  • 4.5.2: ROW Market by End Use: Hospital, Diagnostic Center, and Ambulatory Care Center (ACC)

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Lacrimal Device Market by Product
  • 6.1.2: Growth Opportunities for the Global Lacrimal Device Market by Application
  • 6.1.3: Growth Opportunities for the Global Lacrimal Device Market by End Use
  • 6.1.4: Growth Opportunities for the Global Lacrimal Device Market by Region
• 6.2: Emerging Trends in the Global Lacrimal Device Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Lacrimal Device Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Lacrimal Device Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: FCI Ophthalmic
• 7.2: Kaneka
• 7.3: Lacrimedics
• 7.4: Cook
• 7.5: BVI
• 7.6: Rumex International
• 7.7: Bess Medical Technology